Back to Journals » OncoTargets and Therapy » Volume 7

Review

Profile of trebananib (AMG386) and its potential in the treatment of ovarian cancer

       
Total article views   HTML views PDF downloads Totals
11,837 Dovepress* 9,415+ 1,546 10,961
PubMed Central* 2,422 455 2,877
Totals 11,837 2,001 13,838
*Since 4 October 2014
+Since July 2016

View citations on PubMed Central and Google Scholar